Free shipping on all orders over $ 500

Bavdegalutamide (ARV-110)

Cat. No. M10306

All AbMole products are for research use only, cannot be used for human consumption.

Bavdegalutamide (ARV-110) Structure
Synonym:

ARV110

Size Price Availability Quantity
5mg USD 130  USD130 In stock
10mg USD 200  USD200 In stock
25mg USD 400  USD400 In stock
50mg USD 520  USD520 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Bavdegalutamide (ARV-110) is an oral, specific androgen receptor (AR) PROTAC degrader. ARV-110 promotes ubiquitination and degradation of AR. ARV-110 degrades clinically relevant mutant AR proteins (WT AR, F876L, T877A, M896V and H874V) and retains activity in a high androgen environment in VCaP cells.

In vivo, ARV-110 (1 mg/kg; oral gavage QD) exhibits a greater than 90% AR degradation.

Product Citations
Chemical Information
Molecular Weight 812.29
Formula C41H43ClFN9O6
CAS Number 2222112-77-6
Solubility (25°C) DMSO 16 mg/mL
Storage -20°C, sealed
References

[1] Shenxin Zeng, et al. Eur J Med Chem. Proteolysis targeting chimera (PROTAC) in drug discovery paradigm: Recent progress and future challenges

[2] Cancer Discov. Proof-of-Concept with PROTACs in Prostate Cancer

[3] Yang Wang, et al. Acta Pharm Sin B. Degradation of proteins by PROTACs and other strategies

Related Androgen Receptor Products
LGD-3303

LGD-3303 is a nonsteroidal, nonaromatizable selective androgen receptor ligand that binds to the androgen receptor with high affinity in a radiolabeled to competitive binding assay (Ki=0.9 nM).

Ar-V7-IN-1

Ar-V7-IN-1 is a potent inhibitor of Ar-V7. AR-V7 is a hormone-independent splice variant of the androgen receptor. Ar-V7-IN-1 has the potential for the research of various indications such as prostate cancer.

SC912

SC912 is a potent and selective AR-V7 inhibitor with IC50 of 0.36 μM. SC912 binds directly to AR-FL and AR-V7 proteins, inhibites nuclear localization and chromatin binding capabilities. SC912 exerts anticancer activity through inhibition of proliferation, induction of cell cycle arrest and apoptosis.

A4B17

A4B17 is an androgen receptor N-terminal inhibitor, which can be used for the research of androgen-responsive prostate cancer.

AZ'3137 

AZ‘3137 is an orally active PROTAC-type androgen receptor (AR) degrader, with a DC50 value of 22 nM.

  Catalog
Abmole Inhibitor Catalog




Keywords: Bavdegalutamide (ARV-110), ARV110 supplier, Androgen Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.